CClinicalTrials.gg
CompletedNCT07017738Updated Jan 9, 2026

Effect of Neural Mobilization in Upper Cross Syndrome

An interventional study of Corrective exercises and Neural mobilization in Upper Cross Syndrome, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-01-09.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

The purpose of this study is to investigate the effect of Neural Mobilization in patients with Upper Cross Syndrome.

Read the detailed description

Upper cross syndrome (UCS) is the tightness of the levator scapulae, pectoralis major, and upper trapezius whereas inhibition of serratus anterior, deep neck flexors more specifically scalene, middle trapezius, lower trapezius, and rhomboids. This condition is given its name because a cross can be drawn across the upper body. One arm of the cross indicates the tight muscles and the other arm of the cross indicates the inhibited muscles.

People suffering from UCS present with a forward head posture (FHP), hunching of the thoracic spine (rounded upper back), elevated and protracted shoulders, scapular winging, and decreased mobility of the thoracic spine. Sometimes, manual work can cause musculoskeletal disorders, for example, the workers who do their work in awkward positions repeat the same action throughout their workday.

It was found that UCS causes pain among 24.3% of drivers. Also, 35.9% of office workers suffer from the upper cross syndrome and body posture was the leading cause. Housewives were also suffering from upper cross syndrome. The reason behind this is that during household tasks they don't keep a good posture which causes them pain and other difficulties.

Patients complaining of non-traumatic neck pain tend to keep the forward head posture, when compared to people without pain.

Rounded shoulder has been identified as a leading cause of upper quarter pain. Kyphosis, by both clinical and quantitative assessment, causes diminished function especially in tasks that require mobility.

The effect of neural mobilization in various diseases and conditions includes increasing nerve conduction and functional status, decreasing pain and subjective symptoms.

Accordingly, there are no available studies in the literature investigating the effect of neural mobilization on the upper cross syndrome, therefore this is the purpose of the study.

02

Conditions studied

  • Upper Cross Syndrome
03

In context

Oculocerebral hypopigmentation syndrome type Preus

33 studies on the registry are indexed under Oculocerebral hypopigmentation syndrome type Preus; 19 are open to participants now.

This study's enrollment of 60 is above the median of 48 across 31 interventional studies indexed under Oculocerebral hypopigmentation syndrome type Preus.

Browse Oculocerebral hypopigmentation syndrome type Preus studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age ranged from 20 to 50 years.
  • Body Mass Index ≤30 kg/m².
  • All participants have a forward head, craniovertebral angle \< 50°.
  • All participants have round back (kyphosis angle ≥ 42°).
  • All participants have rounded shoulders of ≥ 52°.
  • The subjects were chosen from both genders based on an assessment of upper cross syndrome by photogrammetric analysis.
  • All participants have pain intensity level measured by visual analogue scale (4-8).
  • All participants tested positive for upper limb tension test of median nerve.

Exclusion criteria

Exclusion Criteria:

  • History of trauma or surgery in the cervical region.
  • Bone fractures or acute soft tissue injuries.
  • Osteoporosis.
  • Pregnant women.
  • Cancer.
  • Neurological conditions affecting cervical and thoracic spine.
  • Connective tissue disease: This includes diseases such as osteomyelitis, lupus, and scleroderma.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Neural mobilization + Corrective exercises

    They will receive neural mobilization in addition to corrective exercises for UCS, 3 times per week for 6 weeks.

    Other: Corrective exercises · Other: Neural mobilization

  • Active comparator
    Corrective exercises

    They will receive corrective exercise for UCS, 3 times per week for 6 weeks.

    Other: Corrective exercises

Interventions

  • OtherCorrective exercises

    The corrective exercise program will include various positions: in standing, scapular retraction and arms overhead; in sitting, chin tuck and thoracic extension; in supine, arms in a W shape and horizontal abduction with external rotation; in side-lying, forward flexion starting with arms parallel to the body; and in prone, scapular retraction and depression in a T shape, extension from 90° forward flexion, and horizontal abduction at 90° with external rotation. Exercises will start with three repetitions held for 10 seconds and progress to six repetitions held for 25 seconds, based on overload principles and individual needs. Participants experiencing pain may stop and rest until symptoms subside.

  • OtherNeural mobilization

    Median nerve mobilization will be performed with the patient in a supine position, shoulder abducted to 90°, elbow flexed at 90°, and both wrist and head in a neutral position. The therapist will mobilize the nerve by extending the elbow to 45°, while the patient performs ipsilateral cervical lateral flexion to unload the nervous system.

06

What researchers measure

Primary outcomes

  1. Forward head angle

    The forward head angle between the line connecting the tragus and C7 with the perpendicular line will be measured for all participants in both groups pre- and post-treatment, using the photogrammetric method.

    Time frame: 6 weeks

  2. Rounded shoulder angle

    The rounded shoulder angle between the line between the acromion process and C7 with the perpendicular line will be measured for all participants in both groups pre- and post-treatment, using the photogrammetric method.

    Time frame: 6 weeks

  3. Kyphosis angle

    For the kyphosis angle, the bone marker on the spinous process of C7 will be used as the starting point of the arch and the spinous process of T12 will be used as the endpoint of the arch. It will be measured for all participants in both groups pre- and post-treatment, using the photogrammetric method.

    Time frame: 6 weeks

Secondary outcomes

  1. Boston Questionnaire (Arabic version)

    The Boston Questionnaire is a patient-reported outcome measure that has demonstrated reliability, validity, and responsiveness to both surgical and non-surgical treatments. The Arabic version has also been shown to be reliable and valid among Arabic-speaking patients. The questionnaire consists of two separate scales: the Symptom Severity Scale (SSS), which includes 11 questions, and the Functional Status Scale (FSS), which includes 8 items. Respondents rate the difficulty of each item using a five-point scale. Higher scores indicate greater symptom severity or functional impairment.

    Time frame: 6 weeks

07

Study locations

1 site
  • Cairo University
    Giza, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07017738
Lead sponsor
Cairo University
Responsible party
Essam Ahmed Abdelbaky Abdelbaky (Principal Investigator, Cairo University) — Principal investigator
First posted
Jun 12, 2025
Start date
Jun 10, 2025
Primary completion
Dec 10, 2025
Completion
Dec 15, 2025
Last update
Jan 9, 2026

Study contacts

Abeer Abdelrahman, PhD
study chair · Professor, Cairo university

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion